Tag Archives: Ahead

Podcast: KHN’s ‘What The Health?’ Live From D.C.: A Look Ahead At Health Policy In 2019

(From left) Tom Miller, Kimberly Leonard, Anna Edney, Joanne Kenen and Julie Rovner(Lynne Shallcross/KHN) The 2020 presidential campaign has begun and health is a big part of it, with Democratic candidates pledging their support for “Medicare-for-all” and many of its variations. Meanwhile, Republicans and Democrats are both promising to do something about drug prices and… Read More »

AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus approval, phase 3 data

The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »